Explore the full directors' dealings record of FERMENTALG, a listed issuer based in France. Shares trade on FR FR, under the oversight of AMF. Operating in the Food & Agriculture sector, FERMENTALG has recorded 80 insider filings. Market capitalisation: €48m. The latest transaction was reported on 26 November 2025 — Acquisition d'actions gratuites. Among the most active insiders: Bpifrance Participations SA. The full history is accessible without an account.
FY ended December 2025 · cache
0 of 0 declarations
Fermentalg is a French industrial biotechnology company focused on the design, production and commercialization of solutions derived from microalgae. Founded in 2009 in Libourne, in the Gironde region of France, the company was built on the idea that microalgae can serve as a powerful technology platform to address major challenges in health, nutrition and sustainability. Listed on Euronext Growth Paris, Fermentalg has evolved from a pioneering start-up into a recognized industrial player in microalgae biotechnology, with capabilities spanning research, development, industrial scale-up and commercialization. Fermentalg’s core business is centered on natural BioSolutions for human nutrition, animal nutrition and functional ingredients. Its portfolio includes algal omega-3 ingredients under the ΩRIGINS™ brand, aimed at vegan and vegetarian consumers as well as food and nutrition manufacturers seeking a traceable, sustainable alternative to marine-sourced oils. The company also develops natural microalgae-based ingredients for colorants, antioxidants and other functional applications, while maintaining broader innovation efforts in areas such as photosynthesis-based carbon capture. From a historical perspective, Fermentalg has passed several important milestones. In 2010, it identified a unique microalgae strain, followed by the industrialization of omega-3 oils between 2014 and 2019. In 2017, the company sharpened its strategy around three core programs: functional lipids, natural proteins and carbon capture through photosynthesis. It has also formed strategic partnerships with major industrial groups, including Givaudan for a natural blue colorant, Suez through the CarbonWorks joint venture, and HuvePharma for industrial-scale omega-3 production. More recently, in April 2026, Fermentalg launched a new EPA/DHA omega-3 generation, underscoring its ongoing innovation drive and ambition to strengthen its nutritional ingredients platform. Geographically, the company remains anchored in Libourne, southwestern France, while serving an international ecosystem of partners and customers. Its model combines scientific expertise, intellectual property, industrial partnerships and commercialization capabilities. Notable features of the company also include ESG-related certifications and a governance framework presented as aligned with the standards expected from listed mid-cap companies. Overall, Fermentalg positions itself as a European specialist in microalgae, operating at the intersection of food ingredients, health nutrition and sustainable biotechnology.